New Technology Allows Fast, Reliable Pathogen Identification
Life-threatening bacterial infections cause tens of thousands of deaths every year in North America but current methods of culturing bacteria in the lab can take days to report the specific source of the infection, and even longer to pinpoint the right antibiotic that will clear the infection.
The new technology, reported in the journal Nature Communications , can identify the pathogen in a matter of minutes, and looks for many different bacteria and drug resistance markers in parallel, allowing rapid and specific identification of infectious agents.
“Overuse of antibiotics is driving the continued emergence of drug-resistant bacteria,” said Shana Kelley (Pharmacy and Biochemistry), a senior author of the study. “A chief reason for use of ineffective or inappropriate antibiotics is the lack of a technology that rapidly offers physicians detailed information about the specific cause of the infection.”
The researchers developed an integrated circuit that could detect bacteria at concentrations found in patients presenting with a urinary tract infection. “The chip reported accurately on the type of bacteria in a sample, along with whether the pathogen possessed drug resistance,” explained Chemistry PhD student Brian Lam, the first author of the study.
One key to the advance was the design of an integrated circuit that could accommodate a panel of many biomarkers. “The team discovered how to use the liquids in which biological samples are immersed as a ‘switch’ – allowing us to look separately for each biomarker in the sample in turn,” said Ted Sargent (Electrical and Computer Engineering), the other senior author of the report.
“The solution-based circuit chip rapidly and identifies and determines the antibiotic resistance of multiple pathogens – this represents a significant advance in biomolecular sensing,” said Paul S. Weiss, Kavli Chair in NanoSystems Science and Director of the California NanoSystems Institute at UCLA.
Ihor Boszko, Director of Business Development at Xagenic, a Toronto-based in vitro diagnostics company said the breakthrough could have significant practical implications. "This kind of highly sensitive, enzyme-free electrochemical detection technology will have tremendous utility for near patient clinical diagnostics. Multiplexing of in vitro diagnostic approach adds the capability of simultaneously testing for multiple viruses or bacteria that produce similar clinical symptoms. It also allows for simple and cost effective manufacturing of highly multiplexed electrochemical detectors, which will certainly have a significant impact on the availability of effective diagnostic tools."
Other authors of the paper were Jagotamoy Das (Chemistry), Richard Holmes (Pharmacy), Ludovic Live (IBBME) and Andrew Sage (IBBME). The paper , "Solution-based circuits enable rapid and multiplexed pathogen detection," can be found at http://www.nature.com/ncomms/2013/130612/ncomms3001/full/ncomms3001.html
Source: University of Toronto
Published on : Tue, 18 Jun 2013
Print as PDF
FeaturesSV 300 is a state-of-the-art ventilator that’s simple to configure, easy to operate and versatile in use. It equips with extensive ventilation modes that can treats pediatric and adult patients with all acuity levels at ICUs and Intermediate Care.With...
Always in sight, always in mind Features Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands. With visionary-stimulating...
The HAMILTON-C3 ventilator is a modular high-end ventilation solution for all patient groups. Offering a number of unique features, the HAMILTON-C3 is one of the first ventilators featuring the “Ventilation Autopilot” INTELLiVENT-ASV®. The HAMILTON-C3’s...
NovaPort cannulas: The safe access to the vascular system. NovaPort® twin double lumen cannulas are specifically developed for veno-venous vascular access. NovaPort one single lumen cannulas are specifically developed for the percutaneous connection (KU)...
The HAMILTON-MR1 guarantees uncompromised continuous ventilation care from the ICU to the MRI scanner and back. Its reliability and high performance, with advanced lung-protective strategies and patient-adaptive modes, make the HAMILTON-MR1 the ideal...